Halozyme Therapeutics Inc (NASDAQ:HALO)

18.52
BATS BZX Real-Time Price
As of 1:06pm ET
 -0.08 / -0.43%
Today’s Change
11.41
Today|||52-Week Range
21.48
-8.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-68.4M-32.2M-103.0M63.0M
 
 
 
 
 
Depreciation1.8M1.7M2.4M2.2M
 
 
 
 
 
Total Other Cash Flow19.0M23.0M33.3M48.2M
 
 
 
 
 
Funds From Operations-47.6M-7.6M-67.4M113.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-106.0K29.5M-17.0M-20.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-47.5M-37.1M-50.4M134.1M
 
 
 
 
 
 
InvestingIncrease In Investments-88.9M-71.5M-155.4M-398.2M
 
 
 
 
 
Decrease In Investments57.3M79.7M81.8M235.8M
 
 
 
 
 
Capital Expenditures-1.4M-2.4M-3.1M-1.4M
 
 
 
 
 
Net Cash Flow Investing-33.0M5.9M-76.8M-163.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.00203.0M0.00
 
 
Long Term Debt Reduction0.000.00-54.3M-16.0M
 
 
 
Net Proceeds Stock Sale114.5M13.1M1.9M147.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing114.5M13.1M150.6M131.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash34.0M-18.1M23.5M102.0M